Skip to main content
Erschienen in: Endocrine 1/2021

21.06.2021 | Original Article

The association between vitamin D3 and diabetes in both hyperuricemia and non-hyperuricemia populations

verfasst von: Rongpeng Gong, Zixin Xu, Xiaoxing Wei

Erschienen in: Endocrine | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Previous studies have shown that hyperuricemia is involved in diabetes, obesity, hypertension, chronic kidney disease, and other diseases. At the same time, studies have shown that vitamin D3 levels in the body are linked to the onset of diabetes. However, there is currently no sufficient evidence to prove whether this connection is affected by the uric acid level. Therefore, we attempted to investigate the association between vitamin D3 content and the occurrence of diabetes in populations with different uric acid levels though the data of NHANES database from 2009 to 2018.

Method

Using the NHANES database, we performed a cross-sectional analysis. The participants were chosen based on stringent inclusion and exclusion requirements. This study finally included a total number of 16,735 individuals. Multivariate logistic regression analysis was used to investigate the association between vitamin D3 and diabetes mellitus in hyperuricemia and non-hyperuricemia patients after complete adjustment, and multivariate linear regression analysis was used to illustrate the association between vitamin D3 and uric acid.

Result

The results showed that the association between vitamin D3 and diabetes was weakened in hyperuricemia patients (OR 0.95 (0.92,0.98)). An independent association was discovered between vitamin D3 and uric acid (β −0.12 (−0.16, −0.07)) in all groups of population.

Conclusions

This study shows that vitamin D3 content is associated with the incidence of diabetes in people with high level of uric acid. This study offers a fresh perspective on the elements that influence the etiology of diabetes in hyperuricemia patients.
Literatur
1.
Zurück zum Zitat M. Chen-Xu, C. Yokose, S.K. Rai, M.H. Pillinger, H.K. Choi, Contemporary prevalence of gout and hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheumatol. (Hoboken, N. J.) 71(6), 991–999 (2019)CrossRef M. Chen-Xu, C. Yokose, S.K. Rai, M.H. Pillinger, H.K. Choi, Contemporary prevalence of gout and hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheumatol. (Hoboken, N. J.) 71(6), 991–999 (2019)CrossRef
2.
Zurück zum Zitat K.A. Kennel, M.T. Drake, D.L. Hurley, Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin. Proc. 85(8), 752–758 (2010)CrossRef K.A. Kennel, M.T. Drake, D.L. Hurley, Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin. Proc. 85(8), 752–758 (2010)CrossRef
3.
Zurück zum Zitat P. Song, H. Wang, W. Xia, X. Chang, M. Wang, L. An, Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci. Rep. 8(1), 4314 (2018)CrossRef P. Song, H. Wang, W. Xia, X. Chang, M. Wang, L. An, Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci. Rep. 8(1), 4314 (2018)CrossRef
4.
Zurück zum Zitat J. Liu, L. Tao, Z. Zhao, Y. Mu, D. Zou, J. Zhang, X. Guo, Two-year changes in hyperuricemia and risk of diabetes: a five-year prospective cohort study. J. Diabetes Res. 2018, 6905720 (2018)PubMedPubMedCentral J. Liu, L. Tao, Z. Zhao, Y. Mu, D. Zou, J. Zhang, X. Guo, Two-year changes in hyperuricemia and risk of diabetes: a five-year prospective cohort study. J. Diabetes Res. 2018, 6905720 (2018)PubMedPubMedCentral
5.
Zurück zum Zitat E. Krishnan, K.S. Akhras, H. Sharma, M. Marynchenko, E.Q. Wu, R. Tawk, J. Liu, L. Shi, Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM 106(8), 721–729 (2013)CrossRef E. Krishnan, K.S. Akhras, H. Sharma, M. Marynchenko, E.Q. Wu, R. Tawk, J. Liu, L. Shi, Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM 106(8), 721–729 (2013)CrossRef
6.
Zurück zum Zitat T. Bardin, P. Richette, Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 15(1), 123 (2017)CrossRef T. Bardin, P. Richette, Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 15(1), 123 (2017)CrossRef
7.
Zurück zum Zitat N. Katsiki, N. Papanas, V.A. Fonseca, E. Maltezos, D.P. Mikhailidis, Uric acid and diabetes: is there a link? Curr. Pharm. Des. 19(27), 4930–4937 (2013)CrossRef N. Katsiki, N. Papanas, V.A. Fonseca, E. Maltezos, D.P. Mikhailidis, Uric acid and diabetes: is there a link? Curr. Pharm. Des. 19(27), 4930–4937 (2013)CrossRef
8.
Zurück zum Zitat D.I. Jalal, Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review. Curr. Med. Res. Opin. 32(11), 1863–1869 (2016)CrossRef D.I. Jalal, Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review. Curr. Med. Res. Opin. 32(11), 1863–1869 (2016)CrossRef
9.
Zurück zum Zitat C. Li, M.C. Hsieh, S.J. Chang, Metabolic syndrome, diabetes, and hyperuricemia. Curr. Opin. Rheumatol. 25(2), 210–216 (2013)CrossRef C. Li, M.C. Hsieh, S.J. Chang, Metabolic syndrome, diabetes, and hyperuricemia. Curr. Opin. Rheumatol. 25(2), 210–216 (2013)CrossRef
10.
Zurück zum Zitat S.B. Woyesa, A.T. Hirigo, T.B. Wube, Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr. Disord. 17(1), 76 (2017)CrossRef S.B. Woyesa, A.T. Hirigo, T.B. Wube, Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr. Disord. 17(1), 76 (2017)CrossRef
11.
Zurück zum Zitat C. Borghi, E. Agabiti-Rosei, R.J. Johnson, J.T. Kielstein, E. Lurbe, G. Mancia, J. Redon, A.G. Stack, K.P. Tsioufis, Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur. J. Intern. Med. 80, 1–11 (2020)CrossRef C. Borghi, E. Agabiti-Rosei, R.J. Johnson, J.T. Kielstein, E. Lurbe, G. Mancia, J. Redon, A.G. Stack, K.P. Tsioufis, Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur. J. Intern. Med. 80, 1–11 (2020)CrossRef
12.
Zurück zum Zitat R.J. Johnson, G.L. Bakris, C. Borghi, M.B. Chonchol, D. Feldman, M.A. Lanaspa, T.R. Merriman, O.W. Moe, D.B. Mount, L.G. Sanchez Lozada, E. Stahl, D.E. Weiner, G.M. Chertow, Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. Am. J. Kidney Dis. 71(6), 851–865 (2018)CrossRef R.J. Johnson, G.L. Bakris, C. Borghi, M.B. Chonchol, D. Feldman, M.A. Lanaspa, T.R. Merriman, O.W. Moe, D.B. Mount, L.G. Sanchez Lozada, E. Stahl, D.E. Weiner, G.M. Chertow, Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. Am. J. Kidney Dis. 71(6), 851–865 (2018)CrossRef
13.
Zurück zum Zitat F.E. García-Arroyo, G. Gonzaga, I. Muñoz-Jiménez, M.G. Blas-Marron, O. Silverio, E. Tapia, V. Soto, N. Ranganathan, P. Ranganathan, U. Vyas, A. Irvin, D. Ir, C.E. Robertson, D.N. Frank, R.J. Johnson, L.G. Sánchez-Lozada, Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage. PloS ONE 13(8), e0202901 (2018)CrossRef F.E. García-Arroyo, G. Gonzaga, I. Muñoz-Jiménez, M.G. Blas-Marron, O. Silverio, E. Tapia, V. Soto, N. Ranganathan, P. Ranganathan, U. Vyas, A. Irvin, D. Ir, C.E. Robertson, D.N. Frank, R.J. Johnson, L.G. Sánchez-Lozada, Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage. PloS ONE 13(8), e0202901 (2018)CrossRef
14.
Zurück zum Zitat K. Kostka-Jeziorny, K. Widecka, A. Tykarski, Study of epidemiological aspects of hyperuricemia in Poland. Cardiol. J. 26(3), 241–252 (2019)CrossRef K. Kostka-Jeziorny, K. Widecka, A. Tykarski, Study of epidemiological aspects of hyperuricemia in Poland. Cardiol. J. 26(3), 241–252 (2019)CrossRef
16.
Zurück zum Zitat C. Li, M.C. Hsieh, S.J. Chang, Metabolic syndrome, diabetes, and hyperuricemia. Curr. Opin. Rheumatol. 25(2), 210–216 (2013)CrossRef C. Li, M.C. Hsieh, S.J. Chang, Metabolic syndrome, diabetes, and hyperuricemia. Curr. Opin. Rheumatol. 25(2), 210–216 (2013)CrossRef
18.
Zurück zum Zitat S. Wenclewska, I. Szymczak-Pajor, J. Drzewoski, M. Bunk, A. Śliwińska, Vitamin D supplementation reduces both oxidative DNA damage and insulin resistance in the elderly with metabolic disorders. Int. J. Mol. Sci. 20(12), 2891 (2019).CrossRef S. Wenclewska, I. Szymczak-Pajor, J. Drzewoski, M. Bunk, A. Śliwińska, Vitamin D supplementation reduces both oxidative DNA damage and insulin resistance in the elderly with metabolic disorders. Int. J. Mol. Sci. 20(12), 2891 (2019).CrossRef
20.
Zurück zum Zitat D. Caccamo, S. Ricca, M. Currò, R. Ientile, Health risks of hypovitaminosis D: a review of new molecular insights. Int. J. Mol. Sci. 19(3), 892 (2018)CrossRef D. Caccamo, S. Ricca, M. Currò, R. Ientile, Health risks of hypovitaminosis D: a review of new molecular insights. Int. J. Mol. Sci. 19(3), 892 (2018)CrossRef
21.
Zurück zum Zitat P. Pozzilli, S. Manfrini, A. Crinò, A. Picardi, C. Leomanni, V. Cherubini, L. Valente, M. Khazrai, N. Visalli,IMDIAB group, Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm. Metab. Res. 37(11), 680–683 (2005).CrossRef P. Pozzilli, S. Manfrini, A. Crinò, A. Picardi, C. Leomanni, V. Cherubini, L. Valente, M. Khazrai, N. Visalli,IMDIAB group, Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm. Metab. Res. 37(11), 680–683 (2005).CrossRef
23.
Zurück zum Zitat B. Han, N. Wang, Y. Chen, Q. Li, C. Zhu, Y. Chen, Y. Lu, Prevalence of hyperuricaemia in an Eastern Chinese population: a cross-sectional study. BMJ Open 10(5), e035614 (2020)CrossRef B. Han, N. Wang, Y. Chen, Q. Li, C. Zhu, Y. Chen, Y. Lu, Prevalence of hyperuricaemia in an Eastern Chinese population: a cross-sectional study. BMJ Open 10(5), e035614 (2020)CrossRef
24.
Zurück zum Zitat T. Cederholm, I. Bosaeus, R. Barazzoni, J. Bauer, A. Van Gossum, S. Klek, M. Muscaritoli, I. Nyulasi, J. Ockenga, S.M. Schneider, M.A. de van der Schueren, P. Singer, Diagnostic criteria for malnutrition—an ESPEN Consensus Statement. Clin. Nutr. (Edinb., Scotl.) 34(3), 335–340 (2015)CrossRef T. Cederholm, I. Bosaeus, R. Barazzoni, J. Bauer, A. Van Gossum, S. Klek, M. Muscaritoli, I. Nyulasi, J. Ockenga, S.M. Schneider, M.A. de van der Schueren, P. Singer, Diagnostic criteria for malnutrition—an ESPEN Consensus Statement. Clin. Nutr. (Edinb., Scotl.) 34(3), 335–340 (2015)CrossRef
25.
Zurück zum Zitat WHO Expert Consultation, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (Lond., Engl.) 363(9403), 157–163 (2004)CrossRef WHO Expert Consultation, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (Lond., Engl.) 363(9403), 157–163 (2004)CrossRef
26.
Zurück zum Zitat L.A. Lotta, A. Abbasi, S.J. Sharp, A.S. Sahlqvist, D. Waterworth, J.M. Brosnan, R.A. Scott, C. Langenberg, N.J. Wareham, Definitions of metabolic health and risk of future type 2 diabetes in BMI categories: a systematic review and network meta-analysis. Diabetes Care 38(11), 2177–2187 (2015)CrossRef L.A. Lotta, A. Abbasi, S.J. Sharp, A.S. Sahlqvist, D. Waterworth, J.M. Brosnan, R.A. Scott, C. Langenberg, N.J. Wareham, Definitions of metabolic health and risk of future type 2 diabetes in BMI categories: a systematic review and network meta-analysis. Diabetes Care 38(11), 2177–2187 (2015)CrossRef
27.
Zurück zum Zitat American Diabetes Association, (2) Classification and diagnosis of diabetes. Diabetes Care 38(Suppl), S8–S16 (2015)CrossRef American Diabetes Association, (2) Classification and diagnosis of diabetes. Diabetes Care 38(Suppl), S8–S16 (2015)CrossRef
28.
Zurück zum Zitat G.E. White, C. Mair, G.A. Richardson, A.P. Courcoulas, W.C. King, Alcohol Use Among U.S. adults by weight status and weight loss attempt: NHANES, 2011-2016. Am. J. Prevent. Med. 57(2), 220–230 (2019)CrossRef G.E. White, C. Mair, G.A. Richardson, A.P. Courcoulas, W.C. King, Alcohol Use Among U.S. adults by weight status and weight loss attempt: NHANES, 2011-2016. Am. J. Prevent. Med. 57(2), 220–230 (2019)CrossRef
29.
Zurück zum Zitat W.J. Elliott, Systemic hypertension. Curr. Probl. Cardiol. 32(4), 201–259 (2007)CrossRef W.J. Elliott, Systemic hypertension. Curr. Probl. Cardiol. 32(4), 201–259 (2007)CrossRef
30.
Zurück zum Zitat C. Ricci, A.E. Schutte, R. Schutte, C.M. Smuts, M. Pieters, Trends in alcohol consumption in relation to cause-specific and all-cause mortality in the United States: a report from the NHANES linked to the US mortality registry. Am. J. Clin. Nutr. 111(3), 580–589 (2020)CrossRef C. Ricci, A.E. Schutte, R. Schutte, C.M. Smuts, M. Pieters, Trends in alcohol consumption in relation to cause-specific and all-cause mortality in the United States: a report from the NHANES linked to the US mortality registry. Am. J. Clin. Nutr. 111(3), 580–589 (2020)CrossRef
31.
Zurück zum Zitat K.M. Flegal, D. Kruszon-Moran, M.D. Carroll, C.D. Fryar, C.L. Ogden, Trends in obesity among adults in the United States, 2005 to 2014. J. Am. Med. Assoc. USA 315(21), 2284–2291 (2016)CrossRef K.M. Flegal, D. Kruszon-Moran, M.D. Carroll, C.D. Fryar, C.L. Ogden, Trends in obesity among adults in the United States, 2005 to 2014. J. Am. Med. Assoc. USA 315(21), 2284–2291 (2016)CrossRef
34.
Zurück zum Zitat K. Łach, K. Krajewski-Siuda, Witamina D3 w prewencji chorób u dorosłych-przeglad systematyczny [Vitamin D3 in prevention of diseases in adults-a systematic review]. Wiadomosci Lekarskie (Warsaw, Poland: 1960) 63, 316–330 (2010) K. Łach, K. Krajewski-Siuda, Witamina D3 w prewencji chorób u dorosłych-przeglad systematyczny [Vitamin D3 in prevention of diseases in adults-a systematic review]. Wiadomosci Lekarskie (Warsaw, Poland: 1960) 63, 316–330 (2010)
37.
Zurück zum Zitat C. Gagnon, R.M. Daly, A. Carpentier, Z.X. Lu, C. Shore-Lorenti, K. Sikaris, S. Jean, P.R. Ebeling, Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS ONE 9(10), e109607 (2014). https://doi.org/10.1371/journal.pone.0109607CrossRefPubMedPubMedCentral C. Gagnon, R.M. Daly, A. Carpentier, Z.X. Lu, C. Shore-Lorenti, K. Sikaris, S. Jean, P.R. Ebeling, Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS ONE 9(10), e109607 (2014). https://​doi.​org/​10.​1371/​journal.​pone.​0109607CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Berridge M. J. Vitamin D deficiency and diabetes. Biochem. J. 474(8), 1321–1332 (2017) Berridge M. J. Vitamin D deficiency and diabetes. Biochem. J. 474(8), 1321–1332 (2017)
40.
Zurück zum Zitat P. Lips, M. Eekhoff, N. van Schoor, M. Oosterwerff, R. de Jongh, Y. Krul-Poel, S. Simsek, Vitamin D and type 2 diabetes. J. Steroid Biochem. Mol. Biol. 173, 280–285 (2017)CrossRef P. Lips, M. Eekhoff, N. van Schoor, M. Oosterwerff, R. de Jongh, Y. Krul-Poel, S. Simsek, Vitamin D and type 2 diabetes. J. Steroid Biochem. Mol. Biol. 173, 280–285 (2017)CrossRef
41.
Zurück zum Zitat G.E. Fagundes, T.P. Macan, P. Rohr, A.P. Damiani, F.R. Da Rocha, M. Pereira, L.M. Longaretti, T.C. Vilela, L.B. Ceretta, C. Mendes, P. Silveira, J. Teixeira, V.M. de Andrade, Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability. Mutagenesis 34(2), 135–145 (2019)CrossRef G.E. Fagundes, T.P. Macan, P. Rohr, A.P. Damiani, F.R. Da Rocha, M. Pereira, L.M. Longaretti, T.C. Vilela, L.B. Ceretta, C. Mendes, P. Silveira, J. Teixeira, V.M. de Andrade, Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability. Mutagenesis 34(2), 135–145 (2019)CrossRef
43.
Zurück zum Zitat K. Chaudhary, K. Malhotra, J. Sowers, A. Aroor, Uric acid—key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 3(3), 208–220 (2013).CrossRef K. Chaudhary, K. Malhotra, J. Sowers, A. Aroor, Uric acid—key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 3(3), 208–220 (2013).CrossRef
44.
Zurück zum Zitat T. Matsuoka, Y. Kajimoto, H. Watada, H. Kaneto, M. Kishimoto, Y. Umayahara, Y. Fujitani, T. Kamada, R. Kawamori, Y. Yamasaki, Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Investig. 99(1), 144–150 (1997).CrossRef T. Matsuoka, Y. Kajimoto, H. Watada, H. Kaneto, M. Kishimoto, Y. Umayahara, Y. Fujitani, T. Kamada, R. Kawamori, Y. Yamasaki, Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Investig. 99(1), 144–150 (1997).CrossRef
45.
Zurück zum Zitat G. Shen, J.Y. Huang, Y.Q. Huang, Y.Q. Feng, The relationship between telomere length and cancer mortality: data from the 1999-2002 National Healthy and Nutrition Examination Survey (NHANES). J. Nutr. Health Aging 24(1), 9–15 (2020)CrossRef G. Shen, J.Y. Huang, Y.Q. Huang, Y.Q. Feng, The relationship between telomere length and cancer mortality: data from the 1999-2002 National Healthy and Nutrition Examination Survey (NHANES). J. Nutr. Health Aging 24(1), 9–15 (2020)CrossRef
Metadaten
Titel
The association between vitamin D3 and diabetes in both hyperuricemia and non-hyperuricemia populations
verfasst von
Rongpeng Gong
Zixin Xu
Xiaoxing Wei
Publikationsdatum
21.06.2021
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02778-y

Weitere Artikel der Ausgabe 1/2021

Endocrine 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.